Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ONCOSOFT logo — AI-based contouring for advanced care

ONCOSOFT

AI-based contouring for advanced care

Founded 2019 Korea South Korea South 16 employees Series A Total: $3.00B Health Care

General Information

Company Name ONCOSOFT
Founded Year 2019
Location Korea South Korea South
Employees 16
Industries Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with ONCOSOFT. To contact ONCOSOFT, visit oncosoft.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ONCOSOFT compare?

A PDF of ONCOSOFT and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ONCOSOFT soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ONCOSOFT

Oncosoft is a cutting-edge startup focused on creating intelligent software solutions tailored to propel the field of precision cancer therapy through AI-driven tools and comprehensive oncology management systems. Founded in 2019, the company's slogan "Crafting intelligent software solutions to advance precision cancer therapy through AI-driven tools and comprehensive oncology management systems" exemplifies its commitment to leveraging technology in the fight against cancer. Oncosoft's specialized software portfolio comprises an Oncology Information Management Solution (OIMS) and AI-driven technologies specifically tailored for radiologists. These solutions serve as vital support in cancer detection and play an essential role in advancing precision cancer therapy within the medical community. The startup's recent milestone includes a significant KRW3.00B Venture Round investment on 22 August 2022, with funding from prominent investors such as HB Investment and BNH Investment. This latest investment stands as a testament to the confidence that key players in the investment landscape have in Oncosoft's potential to make a significant impact in the field of cancer treatment and detection.

Business keywords: precision cancer therapy, oncology management, AI-driven tools, cancer detection, radiology technology, medical software solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A KRW3.00B 2
HB Investment BNH Investment
HB Investment, BNH Investment
22 Aug 2022
Seed Round Undisclosed 2
Devsisters Ventures HB Investment
Devsisters Ventures, HB Investment
01 Jan 2021
Non Equity Assistance Undisclosed 1
TIPS Program
01 Oct 2020

ONCOSOFT Alternatives & Competitors

View All Alternatives
ONCOSOFT vs
Echoliv
Echoliv

Crafting AI-driven solutions for abdominal ultrasound, providing early-stage screening to detect liv...

Pre-Seed
2-10 employees
AI, Biotechnology
ONCOSOFT vs
Central Alabama Radiation Oncology
Central Alabama Radiation Oncology United States

Where Compassion Meets Precision

32 employees
Health Care, Health and Wellness
ONCOSOFT vs
Ezra
Ezra United States

Detecting cancer early using Full Body MRIs

Series B
81 employees
AI, Health Care
Also compare with: ONCOSOFT vs Avicenna.AI Avicenna.AI View all alternatives

FAQ About ONCOSOFT

AI-based contouring for advanced care
ONCOSOFT was founded in 2019.
ONCOSOFT is headquartered in Korea South.
ONCOSOFT operates in Health Care. Its work centres on precision cancer therapy, oncology management, AI-driven tools and cancer detection.
ONCOSOFT has approximately 16 employees.
ONCOSOFT has completed 3 funding rounds, raising a total of $3.00B. The latest funding stage is Series A.
Top alternatives and competitors to ONCOSOFT include Echoliv, Central Alabama Radiation Oncology, Ezra, Avicenna.AI, ViewRay, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ONCOSOFT and Echoliv are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ONCOSOFT, https://bouncewatch.com/company/oncosoft-1, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes